The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riley, M. P.
Right arrow Articles by Caton, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riley, M. P.
Right arrow Articles by Caton, A. J.
The Journal of Immunology, 2000, 165: 4870-4876.
Copyright © 2000 by The American Association of Immunologists

Graded Deletion and Virus-Induced Activation of Autoreactive CD4+ T Cells1

Michael P. Riley, Douglas M. Cerasoli2, Martha S. Jordan, Andria L. Petrone, Fei F. Shih3 and Andrew J. Caton4

The Wistar Institute, Philadelphia, PA 19104


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
We have examined factors governing the negative selection of autoreactive CD4+ T cells in transgenic mice expressing low (HA12 mice) vs high (HA104 mice) amounts of the influenza virus hemagglutinin (HA). When mated with TS1 mice that express a transgenic TCR specific for the I-Ed-restricted determinant site 1 (S1) of HA, thymocytes expressing high levels of the clonotypic TCR were deleted in both HA-transgenic lineages. However, through allelic inclusion, thymocytes with lower levels of the clonotypic TCR evaded deletion in TS1 x HA12 and TS1 x HA104 mice to graded degrees. Moreover, in both lineages, peripheral CD4+ T cells could be activated by the S1 peptide in vitro, and by influenza virus in vivo. These findings indicate that allelic inclusion can allow autoreactive CD4+ thymocytes to evade thymic deletion to varying extents reflecting variation in the expression of the self peptide, and can provide a basis for the activation of autoreactive peripheral T cells by viruses bearing homologues of self peptides ("molecular mimicry").


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
It is now well established that autoreactive thymocytes can be deleted during their development (1, 2, 3, 4). Nevertheless, that autoimmune diseases occur indicates that the negative selection of autoreactive thymocytes can be incomplete. Autoreactive T cells that are present in the peripheral repertoire appear, in some studies, to have been rendered nonresponsive to the self Ag (5, 6). However, in other cases, autoreactive T cells could become autoaggressive either spontaneously or following receipt of appropriate signals (e.g., infection with a virus bearing a homologue of the self peptide; Refs. 7, 8, 9). Previous studies have provided evidence that thymocytes bearing TCRs with low avidities for self peptides (10, 11), or that express low levels of high avidity autoreactive TCRs (and/or low levels of coreceptor molecules; Refs. 12, 13, 14, 15), can evade negative selection presumably because their sensitivity for their cognate self peptide is insufficient to trigger negative selection (16). Recently, it has been reported that the expression of two different TCR {alpha}-chains ("allelic inclusion") in both TCR-transgenic (Tg)5 and non-Tg systems may similarly allow thymocytes expressing low levels of autoreactive TCRs to evade thymic deletion (4, 17, 18, 19, 20, 21). There is also evidence that thymocytes that are specific for self peptides which are presented at low levels in the thymus (such as tissue-specific Ags) can, in some cases, evade negative selection and be exported to the periphery (8, 9, 22). Although these and other studies (23, 24, 25) suggest that negative selection can be sensitive to both the avidity of the autoreactive thymocyte for its cognate self peptide and the amount of self peptide that is presented in the thymus, how these parameters interact to determine the efficiency of negative selection of autoreactive CD4+ T cells in vivo is not well understood.

In this report, we set out to examine how variation in the expression of an MHC class II-restricted self peptide can affect the degree to which autoreactive CD4+ T cells are negatively selected. We mated two separate lineages of Tg mice that express different amounts of the influenza virus hemagglutinin (HA) as a neo-self Ag (designated HA12 and HA104 mice) with TS1 mice, that express a Tg TCR with specificity for the major I-Ed-restricted T cell determinant from the HA (site 1 (S1)). We show that T cells expressing high levels of the clonotypic TCR are substantially deleted in both TS1 x HA12 and TS1 x HA104 mice. However, T cells that express low levels of the clonotypic TCR via allelic inclusion evaded deletion to different extents in TS1 x HA12 and TS1 x HA104 mice. We further show that T cells from both TS1 x HA12 and TS1 x HA104 mice can nevertheless use the clonotypic TCR to proliferate in response to S1 peptide in vitro, and in response to virus immunization in vivo. These findings demonstrate that the negative selection of autoreactive CD4+ T cells can be influenced by variations in self Ag expression, and that allelic inclusion can allow autoreactive CD4+ T cells with differing sensitivities for the self Ag to enter the peripheral T cell repertoire. Moreover, these processes provide a basis for the activation of autoreactive CD4+ T cells in vivo by viruses bearing homologues of self Ags ("molecular mimicry").


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Mice

HA12 and HA104 mice contain DNA encoding either the N-terminal 237 amino acids or full-length polypeptide, respectively, of the influenza virus A/PR/8/34 (PR8) HA linked to the SV40 early region promoter/enhancer sequences as previously described (11, 26). TS1 mice express a transgene-encoded TCR specific for S1, the I-Ed-restricted determinant of PR8 HA (27). Mice referred to as TS1-negative (TS1neg) are TS1 and HA transgene-negative littermates derived from TS1 x HA matings and were used as controls. All lineages were backcrossed to BALB/c mice (Harlan Breeders, Indianapolis, IN) 5–14 generations before use in this study and were maintained in sterile microisolators at the Wistar Institute Animal Facility (Philadelphia, PA).

Flow cytometry

Thymocytes or pooled lymph node (LN) cells from inguinal, brachial, axillary, and cervical LN as well as in vitro-cultured LN cells were analyzed by three-color flow cytometry on a FACScan flow cytometer (Becton Dickinson, San Jose, CA). Live cells from in vitro cultures were washed and purified away from dead cells and other debris using Lympholyte-M before Ab staining. The number of events collected per sample was between 40,000 and 50,000, except for those described in Fig. 4Go, in which case, all events contained in 1/12th of the culture volume were collected. The following mAbs were used for analysis: 6.5-biotin (27), anti-Vß8-biotin (F23.1, American Type Culture Collection, Manassas, VA), anti-CD4-FITC, anti-CD4-PE, and anti-CD8-PE (Life Technologies, Gaithersburg, MD). Streptavidin-Red670 (Life Technologies) was used to detect biotinylated reagents.



View larger version (28K):
[in this window]
[in a new window]
 
FIGURE 4. Cell division of CFSE-labeled LN cells from TS1, TS1 x HA12, and TS1 x HA104 mice. LN cells from TS1, TS1 x HA12, TS1 x HA104, and TS1neg mice were labeled with the dye CFSE and incubated in vitro with unlabeled irradiated APC and either no peptide or 1 µM S1 peptide for 3 days. The cultures were then harvested and stained with anti-CD4 and 6.5 for analysis by flow cytometry. For this analysis, equivalent volumes of each culture were analyzed as opposed to equivalent numbers of cells from each culture. This permits an assessment of relative differences in cell expansion among the different cultures. Top, Dot plots of 6.5 staining vs CFSE intensity gated on live, CD4+ cells. Bottom, Histograms of CFSE intensity also gated on live CD4+ cells. Event count scales on histograms are set to 300 events. Data are representative of at least three experiments.

 
[3H]Thymidine incorporation

Pooled LN cells (5 x 104) were cultured with 5 x 105 irradiated BALB/c splenocytes and graded doses of S1 peptide (SFERFEIFPK) synthesized and purified by the Wistar Institute peptide synthesis facility. Cells were cultured in 200 µl of supplemented IMDM as described (11) in 96-well flat-bottom tissue culture plates. When indicated, IL-2 from the transfectant cell line X-2 was added at a final concentration of 10 ng/ml (28). Cultures were pulsed with 0.5 mCi per well of [3H]thymidine 72 h after activation and were harvested 16 h later.

5-(and 6-)carboxyfluorescein diacetate succinimidyl ester (CFSE) labeling and adoptive transfer experiments

Pooled LN cells were labeled with CFSE (Molecular Probes, Eugene, OR) as previously described (29). Briefly, LN cells were washed in serum-free IMDM, incubated with 5 µM CFSE at 1 x 107 cells/ml, incubated with 50% serum, and washed with supplemented media. For in vitro culture, 1 x 106 CFSE-labeled cells were stimulated with 1 µM S1 peptide and 5 x 106 irradiated BALB/c splenocytes for 3 days before harvest, staining, and analysis by flow cytometry. For adoptive transfer, 1 x 107 CFSE-labeled cells were injected into the tail vein of BALB/c, HA12, or HA104 mice. At the time of the adoptive transfer, recipient mice were immunized s.c. at the tail base either with 2000 hemagglutinating units PR8 virus in CFA or with CFA alone. Four days after adoptive transfer, inguinal LN cells were harvested from the host mice, stained for CD4 and 6.5, and analyzed by flow cytometry.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
S1-specific T cells are deleted to differing degrees in HA12 and HA104 mice

HA12 and HA104 mice contain sequences encoding either the N-terminal 237 amino acids (HA12 mice) or the complete coding sequence (HA104 mice) of the influenza virus PR8 HA linked to the SV40 early-region promoter-enhancer (11, 26). Both lineages express transgene mRNA in the thymus and in peripheral lymphoid tissues; however, higher levels of HA transgene mRNA were detected in HA104 mice than in HA12 mice (11, 26). We have previously shown that PR8-infected HA12 and HA104 mice generate reduced T cell proliferative responses (relative to BALB/c mice) to the major I-Ed-restricted T cell determinant from the HA (termed S1), consistent with induction of tolerance to S1 as a neo-self Ag in both lineages (11, 26).

To determine the mechanism by which S1-specific T cells are tolerized, HA12 and HA104 mice were mated with Tg mice that express a S1-specific TCR (designated TS1 mice), and the fate of developing S1-specific T cells was determined by flow cytometry using the anti-clonotypic Ab 6.5 (27). As previously described (27), 30–40% of mature thymocytes and peripheral T cells in TS1 mice (including CD8+ T cells) express high or intermediate levels of the 6.5 TCR, reflecting incomplete allelic exclusion of endogenous TCR {alpha}-chain rearrangement (Fig. 1Go). By contrast, >98% of T cells express the Tg Vß8.2 chain (27). Mature CD4 single-positive thymocytes and peripheral CD4+ LN cells expressing high levels of the 6.5 TCR (6.5high) were deleted in TS1 x HA12 and TS1 x HA104 mice. However, the degree of deletion of T cells expressing an intermediate amount of the 6.5 TCR (6.5int) differed in the two lineages. TS1 x HA12 mice contained more CD4 single positive 6.5int thymocytes than TS1 x HA104 mice; a similar pattern was apparent among peripheral CD4+ LN cells (Fig. 1Go). Although both double Tg mice contained substantially lower numbers of 6.5high T cells than were present in TS1 mice, the number of CD4+ 6.5int LN cells in TS1 x HA12 mice was reduced only 2.5-fold compared with TS1 mice, whereas the number of CD4+ 6.5int LN cells in TS1 x HA104 mice was 9-fold lower than in TS1 mice. Together, these data indicate that S1-specific thymocytes undergo more substantial deletion in TS1 x HA104 mice than in TS1 x HA12 mice, correlating with higher levels of transgene mRNA.



View larger version (40K):
[in this window]
[in a new window]
 
FIGURE 1. S1-specific T cells are deleted to differing degrees in TS1 x HA12 and TS1 x HA104 mice. Histograms of 6.5 expression on CD4 single positive (SP) thymocytes (A) and CD4+ LN cells (C) from TS1, TS1 x HA12, TS1 x HA104, and TS1neg mice. Thymocytes and LN cells were harvested and stained with 6.5, anti-CD4, and anti-CD8 for analysis by flow cytometry. Markers defining 6.5high, 6.5int, and 6.5low cells are indicated. Data are representative of at least six experiments. Total numbers of 6.5high and 6.5int CD4 SP thymocytes (B) and CD4+ LN cells (D) in TS1, TS1 x HA12, TS1 x HA104, and TS1neg mice were determined based on the absolute number of cells per individual thymus or LNs multiplied by the percent of 6.5high or 6.5int CD4 SP thymocytes or CD4+ LN cells from that mouse. Dots represent the number of cells from individual mice, whereas columns represent the mean values of all mice within that set. This analysis used data from 10 TS1, 8 TS1 x HA12, 6 TS1 x HA104, and 6 TS1neg mice.

 
Autoreactive T cells that evade negative selection in TS1 x HA Tg mice can be activated with S1 peptide via the clonotypic TCR

To examine whether peripheral LN cells that evade deletion by the neo-self S1 peptide in TS1 x HA12 and TS1 x HA104 mice could be activated by the S1 peptide, LN cells were incubated with 1 µM S1 peptide and analyzed by flow cytometry 3 days later (Fig. 2Go). Activation of T cells was assessed by increases in forward and side light scattering properties (Fig. 2GoA). The majority of S1 peptide-stimulated LN cells from TS1neg mice were small and resting, but increased in size in response to anti-CD3 stimulation. When LN cells from the different Tg+ lineages were incubated with S1 peptide, similar increases in size and granularity were observed, although the number of cells undergoing activation progressively decreased in TS1 x HA12 and TS1 x HA104 mice relative to those from TS1 mice. Two points were apparent when the levels of Vß8 and the 6.5 TCR were compared between resting and activated cells. First, the activated cells all expressed equivalent levels of Vß8 (Fig. 2GoB), and therefore had similar TCR densities; however, cells from TS1 x HA12 and TS1 x HA104 mice had lower levels of the 6.5 TCR compared with TS1 T cells (Fig. 2GoC). Second, activated cells from TS1, TS1 x HA12, and TS1 x HA104 mice included cells expressing higher levels of the 6.5 TCR than were present as background staining on cells from TS1neg mice (Fig. 2GoC). This segregation of 6.5 staining with activation indicates that the T cells that evade negative selection because they express low levels of the 6.5 TCR nevertheless use the 6.5 TCR to respond to S1 peptide in vitro.



View larger version (55K):
[in this window]
[in a new window]
 
FIGURE 2. CD4+ T cells in TS1 x HA12 and TS1 x HA104 mice use the 6.5 TCR to respond to S1 peptide stimulation. LN cells from TS1neg, TS1, TS1 x HA12, and TS1 x HA104 mice were incubated in vitro with irradiated APC and either 1 µM S1 peptide or, where indicated by (anti-CD3), with 0.1 µg/ml anti-CD3 mAb. After 3 days, viable cells were isolated with Lympholyte M and stained for CD4, CD8, Vß8, and 6.5 for analysis by flow cytometry. A, Dot plots of forward scatter vs side scatter. Gates defining resting and activated populations and accompanying cell percentages within those gates are indicated. B, Histograms of Vß8 staining on CD4+ resting and activated cells. Event count scales were set to 150 events. C, Histograms of 6.5 staining on CD4+ resting and activated cells. Event count scales were set to 25 and 150 events for the resting and activated gates, respectively. Data are representative of at least three experiments.

 
Autoreactive T cells proliferate to differing extents in response to S1 peptide in vitro

Peripheral T cells from TS1, TS1 x HA12, TS1 x HA104, and TS1neg mice were analyzed for their ability to proliferate in response to S1 peptide in vitro by two approaches. First, LN cells from the various lineages were incubated with graded doses of S1 peptide, and, after 3 days, their proliferation was assessed by [3H]thymidine uptake (Fig. 3GoA). LN cells from TS1 x HA12 mice required roughly 30-fold higher concentrations of S1 peptide to achieve the half-maximal proliferation observed for LN cells from TS1 mice. LN cells from TS1 x HA104 mice were less sensitive than TS1 x HA12 LN cells, but nonetheless displayed proliferative responses that exceeded those of LN cells from TS1neg mice.



View larger version (21K):
[in this window]
[in a new window]
 
FIGURE 3. LN cells from TS1 x HA12 and TS1 x HA104 mice proliferate to different extents in response to S1 peptide in vitro. A, Proliferation analysis by [3H]thymidine incorporation. LN cells from TS1 ({blacksquare}), TS1 x HA12 ({circ}), TS1 x HA104 ({square}), and TS1neg (•) mice were harvested and incubated in vitro with serial 3-fold dilutions of S1 peptide plus irradiated APC. [3H]Thymidine was added for the final 16 h of a 96-h culture before harvest and measurement of [3H]thymidine incorporation. Each data point is the mean of triplicate wells; error bars indicate ± 1 SD. Data are representative of at least six experiments. B, S1-specific proliferation per 6.5+ cell with or without exogenous IL-2. LN cells from TS1, TS1 x HA12, TS1 x HA104, and TS1neg mice were harvested and either stained with 6.5 for analysis by flow cytometry, or incubated in vitro with either 0.1 or 1 µM S1 peptide plus irradiated APC with or without 10 ng/ml exogenous IL-2. [3H]Thymidine was added for the final 16 h of a 96-h culture before harvest and measurement of [3H]thymidine incorporation. The amount of [3H]thymidine incorporation was then divided by the number of 6.5+ LN cells for that mouse. Each data point is the mean of triplicate wells; error bars indicate ± 1 SD. Data are representative of at least three experiments.

 
Several factors could account for the reduced proliferative responses in the TS1 x HA Tg mice. Lower frequencies of S1-specific T cells, decreased avidities for the S1 peptide, or their functional impairment (e.g., anergy induction) could either singly or in concert lead to reduced proliferation of TS1 x HA12 and TS1 x HA104 T cells in response to S1 peptide. To examine these possibilities, proliferation assays were conducted using two doses of S1 peptide (0.1 or 1 µM) in the presence or absence of exogenous IL-2, and the amount of proliferation was adjusted for the number of 6.5+ T cells (6.5+ is equivalent to 6.5high plus 6.5int) in the LN cells from individual mice (Fig. 3GoB). In response to stimulation with 1 µM S1 peptide and in the absence of exogenous IL-2, LN cells from TS1 and TS1 x HA12 mice underwent equivalent proliferation per 6.5+ T cell, and addition of exogenous IL-2 led to ~3-fold increases in the amount of proliferation from both cultures. In contrast, stimulation with a 10-fold lower concentration of S1 peptide (0.1 µM) resulted in substantially less proliferation per 6.5+ T cell in LN cells from TS1 x HA12 than from TS1 mice. The reduced proliferation per 6.5+ T cell exhibited by LN cells from TS1 x HA12 mice in response to lower concentrations of S1 peptide correlates with their lower levels of the 6.5 TCR, and reflects the reduced avidity of these T cells for the S1 peptide. The T cells from TS1 x HA104 mice appeared to have even lower avidities for the S1 peptide: LN cells from TS1 x HA104 mice stimulated with 1 µM S1 peptide were ~6-fold less proliferative than TS1 or TS1 x HA12 LN cells on a per 6.5+ T cell basis when incubated in the absence of IL-2, and little or no proliferation was exhibited in response to 0.1 µM S1 peptide. Moreover, the S1-specific T cells from TS1 x HA104 mice appeared to be more dependent on exogenous IL-2 than either TS1 or TS1 x HA12 T cells for their proliferation when incubated with 1 µM S1 peptide, because the addition of IL-2 caused a much greater increase (~10-fold) in the amount of proliferation than was the case for either TS1 or TS1 x HA12 T cells. Thus, when adjusted for differences in the frequency of 6.5+ T cells, the LN cells from TS1 x HA12 mice appeared less sensitive and proliferated relatively poorly in response to low doses of S1 peptide, but were as responsive as TS1 T cells when incubated with high doses of S1 peptide. The S1-specific T cells from TS1 x HA104 mice, in contrast, proliferated relatively poorly in response to either peptide dose, even when adjusted for their low precursor frequency, and were more sensitive to the addition of exogenous IL-2.

As a second approach to examine their capacity to undergo S1-specific proliferation, LN cells from the different lineages were labeled with the fluorescent dye CFSE, stimulated with 1 µM S1 peptide, and 3 days later, analyzed by flow cytometry (Fig. 4Go). Because CFSE-labeled cells decrease in staining intensity by one-half with each cycle of cell division (29), the extent of cell division in response to S1 peptide could be assessed. Neither TS1 CD4+ T cells incubated in the absence of S1 peptide nor TS1neg CD4+ T cells incubated with S1 peptide underwent significant cell division during the culture period. By contrast, the majority of the CD4+ T cells from TS1 mice underwent division in response to S1 peptide, with the most prominent peaks corresponding to four and five cell divisions. Moreover, most of the CD4+ T cells that divided expressed high or intermediate levels of the 6.5 TCR, although a population of T cells expressing low levels of the 6.5 TCR also underwent division in response to S1 peptide. Significantly, although fewer CD4+ T cells from TS1 x HA12 mice divided in response to S1 peptide compared with TS1 mice, the number of divided cells was substantial and generated a CFSE profile displaying prominent peaks representing cells that had undergone five to six divisions. The CD4+ T cells from TS1 x HA104 mice, in contrast, underwent less division in response to 1 µM S1 peptide than did those from TS1 x HA12 mice, and did not yield clearly defined peaks. Comparison of CFSE intensity with 6.5 staining also revealed that the cells from TS1 x HA12 and TS1 x HA104 mice that underwent division in each case expressed lower levels of the 6.5 TCR, reflecting deletion of 6.5high T cells in these lineages.

Together, these data indicate that the 6.5+ LN cells that persist in TS1 x HA12 and TS1 x HA104 mice can proliferate in response to S1 peptide in vitro, although to differing extents. The 6.5+ T cells from TS1 x HA12 and TS1 mice proliferated similarly on a per cell basis in response to high doses of S1 peptide (1 µM), and activated T cells underwent similar numbers of divisions. However, in response to a lower dose of S1 peptide (0.1 µM), the S1-specific T cells from TS1 x HA12 mice were less proliferative on a per cell basis, reflecting their lower avidities for the S1 peptide. The LN cells from TS1 x HA104 mice were less responsive on a per-cell basis and were more dependent on exogenous IL-2 in their responsiveness to 1 µM S1 peptide, suggesting that lower avidities and/or anergy induction limit their ability to proliferate in response to S1.

Activation of autoreactive S1-specific T cells by PR8 virus in vivo

Because autoreactive T cells from TS1 x HA12 and TS1 x HA104 mice could be activated in vitro in response to S1 peptide, it was of interest to determine whether these T cells were susceptible to activation upon encountering the S1 peptide when presented by a virus particle in vivo. To examine this, LN cells from TS1, TS1 x HA12, and TS1 x HA104 mice were labeled with CFSE and injected into mice with the same HA transgene status but that did not contain the TS1 transgene (i.e., TS1 LN cells into BALB/c mice, TS1 x HA12 LN cells into HA12 mice, and TS1 x HA104 LN cells into HA104 mice). The recipient mice were then immunized either with PR8 virus in CFA or with CFA alone. Although this protocol is not expected to give rise to significant virus replication, it allowed us to compare T cell division that might be induced in response to virus-derived S1 peptide with division that could occur in response to nonspecific inflammatory signals (provided here by the use of CFA). Four days after adoptive transfer and virus immunization, draining LN cells from the mice were harvested and analyzed by flow cytometry (Fig. 5GoA). Transferred CD4+ T cells from TS1, TS1 x HA12, and TS1 x HA104 mice all underwent division in response to immunization with PR8 virus in CFA, as indicated by a progressive loss of CFSE intensity. Significantly, although fewer precursors were activated in LN cells from both TS1 x HA12 and TS1 x HA104 mice than from TS1 mice, autoreactive LN cells in each case underwent multiple rounds of division in response to virus immunization. By contrast, in mice immunized with CFA alone, the few cells found in the low intensity CFSE peak did not exceed in number those detected in control mice that either received CFSE-labeled cells without immunization, or that were immunized but did not receive labeled cells (Fig. 5GoB). Moreover, the CD4+ T cells from TS1, TS1 x HA12, and TS1 x HA104 mice that underwent division expressed levels of 6.5 that paralleled those expressed by in vitro-activated T cells (i.e., high levels of 6.5 on TS1 T cells, and progressively lower levels on TS1 x HA12 and TS1 x HA104 cells) (Figs. 2Go and 5GoC). Accordingly, peripheral autoreactive CD4+ T cells from TS1 x HA12 and TS1 x HA104 mice can be activated and undergo proliferation in vivo in response to a virus that contains the S1 peptide. That division was observed in response to PR8 virus in CFA, but not to CFA alone, indicates that the high concentration of S1 peptide generated from PR8 virus, rather than nonspecific inflammatory signals, led to activation of the autoreactive T cells.



View larger version (35K):
[in this window]
[in a new window]
 
FIGURE 5. LN cells from TS1 x HA12 and TS1 x HA104 mice undergo division in vivo in response to influenza virus. A, LN cells from TS1, TS1 x HA12, and TS1 x HA104 mice were labeled with CFSE and adoptively transferred into host mice with the same HA transgene status but which did not contain the TS1 transgene. Additionally, the adoptive transfer hosts were immunized with either 2000 hemagglutinating units PR8 virus in CFA (upper row) or with CFA alone (lower row). Four days later, LN cells were harvested and stained with anti-CD4 and 6.5 for analysis by flow cytometry. Shown are histograms of CFSE expression on CD4+ LN cells from recipient mice gated to exclude the majority of endogenous LN cells based on 6.5 and CFSE expression. Gates defining divided and undivided cells are shown and the percentage of divided cells indicated in each histogram. B, Control conditions showing identically derived histograms of CFSE expression following transfer of CFSE-labeled TS1 LN cells into a BALB/c host mouse in the absence of immunization (left histogram) and following immunization of a BALB/c mouse with PR8 +CFA in the absence of transferred CFSE-labeled LN cells (right histogram). C, 6.5 staining on CD4+ CFSE-labeled divided (thin line) and undivided (thick line) cells (as defined by the gates shown in A) from PR8 + CFA immunized mice. Event count scales for all histograms are set to 60 events. Data are representative of two experiments using a minimum of two experimental mice per condition.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The findings here demonstrate that the efficiency with which autoreactive CD4+ T cells are negatively selected in vivo can be sensitive to variation in the expression of a thymic self peptide. Although thymocytes expressing high levels of the clonotypic TCR were substantially deleted in both TS1 x HA12 and TS1 x HA104 mice, thymocytes expressing lower levels of the clonotypic TCR could evade deletion via allelic inclusion to different extents that correlated with the levels of transgene mRNA. The CD4+ T cells that evaded deletion in TS1 x HA12 mice had lower avidities than their nonautoreactive TS1 counterparts and proliferated poorly in response to low doses of S1 peptide in vitro, but were as proliferative on a per cell basis as were TS1 T cells when incubated with high doses of S1 peptide. The CD4+ T cells from TS1 x HA104 mice, in contrast, proliferated poorly in response to either low or high doses of S1 peptide in vitro, and were more dependent on the addition of exogenous IL-2. Significantly, however, LN cells from both TS1 x HA12 and TS1 x HA104 mice proliferated in response to a virus containing the S1 peptide in vivo. Thus, variations in self Ag expression and allelic inclusion may each contribute to the ability of viruses bearing homologues of self Ags to activate autoreactive CD4+ T cells ("molecular mimicry").

Although HA12 and HA104 mice both use the SV40 early region promoter/enhancer to drive transgene expression, differences in transgene integration led to higher levels of transgene mRNA expression in HA104 than HA12 mice (26). S1-specific T cells were able to evade negative selection in TS1 x HA12 and TS1 x HA104 mice because they expressed intermediate and low levels of the Tg TCR {alpha}-chain via coexpression of endogenous TCR {alpha}-chains. The ability of T cells to express more than one TCR {alpha}-chain ("allelic inclusion") is not particular to these T cells because ~30% of normal human and murine {alpha}ß T cells express two {alpha}-chains (20, 21). The variable coexpression of endogenous TCR {alpha}-chains most likely reduced the sensitivity of 6.5+ thymocytes for the S1 peptide to varying degrees, and the greater amount of S1 (and/or expression on more cell types) in HA104 vs HA12 mice caused thymocytes with progressively lower densities of the 6.5 TCR to be deleted. Thus, differences in the expression of the S1 peptide affected the extent to which 6.5int T cells were negatively selected in TS1 x HA12 and TS1 x HA104 mice. This finding is similar to other studies examining negative selection of CD4+ T cells specific for neo-self Ags, in which differences in the pattern of transgene expression were found to affect the degree of deletion of autoreactive thymocytes (4, 30). It is likely that variations in the expression of bona fide self peptides can similarly influence the efficiency with which autoreactive CD4+ T cells are negatively selected during thymic development.

Despite substantial deletion of T cells expressing high levels of the 6.5 TCR in both TS1 x HA12 and TS1 x HA104 mice, 6.5int and 6.5low T cells that evaded deletion could nevertheless be activated if they were provided with high concentrations of S1 peptide in vitro. The ability of 6.5int and 6.5low T cells to respond to the S1 peptide is noteworthy in light of a previous study in which autoreactive CD4+ T cells expressing dual TCRs were found to react with their cognate self peptide (in this case C5) only after stimulation via their nonautoreactive TCR {alpha}-chains (19). In the studies here, T cells from TS1 x HA12 and TS1 x HA104 mice appeared to have been activated via the 6.5 TCR in response to S1 peptide stimulation, as evidenced by the segregation of 6.5 staining into the blasting population of T cells following stimulation (Fig. 2Go). Thus, although low levels of the 6.5 TCR allowed T cells to evade negative selection by the S1 peptide during their development by reducing their sensitivity for the S1 peptide, these T cells could nevertheless use the 6.5 TCR to respond to high concentrations of the S1 peptide in vitro and in vivo.

Although both TS1 x HA12 and TS1 x HA104 mice contained peripheral CD4+ T cells that could be activated by the S1 peptide, these peripheral T cells differed in their proliferative capacity following activation. When adjusted for the relative frequency of 6.5+ T cells, LN cells from TS1 x HA12 mice proliferated as well as TS1 LN cells in response to 1 µM S1 peptide in the presence or absence of exogenous IL-2. Likewise, CFSE analysis conducted in the absence of exogenous IL-2 indicated that S1-specific T cells from TS1 and TS1 x HA12 mice underwent equivalent rounds of division in response to this dose of S1 peptide. At a lower dose of S1 peptide (0.1 µM), LN cells from TS1 x HA12 mice were less responsive on a per 6.5+ cell basis than were TS1 LN cells, reflecting the low levels of the 6.5 TCR and reduced avidities that allowed these cells to evade negative selection during thymic development. The LN cells from TS1 x HA104 mice, in contrast, appeared less proliferative on a per 6.5+ cell basis at both 1 µM and 0.1 µM S1 peptide, and were more dependent on the addition of exogenous IL-2 for proliferation. This greater requirement for exogenous IL-2 could reflect the induction of anergy among S1-responsive T cells (5). Using a different lineage of HA Tg mice (designated HA28), we recently showed that HA as a self Ag can induce TS1 cells to become anergic/suppressor cells (6). However, in TS1 x HA28 mice, anergy induction was associated with little thymic clonal deletion, and with a characteristic cell surface phenotype (CD25hi/CD45RBint) that was expressed by 6.5high cells, but not by 6.5int or 6.5low cells (6). Because 6.5high T cells are substantially deleted in TS1 x HA104 mice, it is unlikely that a similar mechanism explains the dependency of these T cells on exogenous IL-2. However, it remains possible that S1-specific T cells are anergized by a distinct mechanism in TS1 x HA104 mice; indeed, anergy induction has previously been proposed for TS1 T cells that evaded deletion in mice that express the HA on hematopoietic cells and in which 6.5high T cells are substantially deleted (31).

An alternative explanation for the poor proliferative responses of T cells from TS1 x HA104 mice is that a combination of the decreased avidity of the TCR for the S1 peptide and the reduced frequency of responsive T cells leads to a greater requirement for exogenous IL-2 (32). Indeed, consistent with this previous study, the LN cells from TS1 x HA12 mice were more responsive to exogenous IL-2 when stimulated with 0.1 µM S1 peptide than when they were stimulated with 1 µM S1 peptide (see Fig. 3GoB). It is possible, then, that a combination of reduced avidity and lower precursor frequency explains the IL-2 dependency of LN cells from TS1 x HA104 mice when stimulated with S1 peptide in vitro. However, significantly, T cells from both TS1 x HA12 and TS1 x HA104 mice underwent division in response to PR8 virus in vivo. The ability of the LN cells from TS1 x HA104 mice to proliferate in vivo in response to virus immunization is particularly noteworthy in light of their dependency on the addition of exogenous IL-2 for proliferation in vitro. Therefore, neither the decreased levels of the 6.5 TCR that allowed these cells to evade deletion, nor peripheral regulatory mechanisms (such as anergy induction or suppression), prevented these autoreactive T cells from being activated by the S1 peptide when presented in the context of a viral Ag.

The in vivo activation of S1-specific T cells from TS1 x HA12 and TS1 x HA104 mice by PR8 virus demonstrates that a viral Ag can activate CD4+ T cells that evade negative selection by a self peptide via allelic inclusion ("molecular mimicry"). Inasmuch as the S1-specific T cells from TS1 x HA12 mice were more proliferative than their TS1 x HA104 counterparts, they would appear to pose the greater threat for mediating autoimmune damage to the host’s tissues. However, in this regard it is noteworthy that the activated S1-specific T cells from TS1 x HA104 mice can contain a higher proportion of effector cells that secrete high levels of IFN-{gamma}, and thus may mediate more potent cell-mediated anti-self responses (33). Because it is likely that variations in the amount and/or pattern of expression of bona fide self peptides can similarly affect the proliferative and/or differentiative capacity of autoreactive T cells that evade thymic deletion, it will be important to determine how these differences influence their capacity to mediate autoimmune disease.


    Acknowledgments
 
We thank Amy J. Reed, Melissa A. Lerman, and Dr. Jan Erikson for thoughtful discussion and critical reading of this manuscript.


    Footnotes
 
1 This work was supported by the National Institutes of Health Grants AI24541 and CA10815. M.P.R. was supported by Medical Scientist Training Program Grant 5-T32-GM07170 and National Institutes of Health Training Grant CA09171. Back

2 Current address: Division of Biochemistry and Pharmacology, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Grounds, Aberdeen, MD 21010. Back

3 Current address: Department of Pediatrics, St. Louis Children’s Hospital, St. Louis, MO 63110. Back

4 Address correspondence and reprint requests to Dr. Andrew J. Caton, The Wistar Institute, Room 262, 3601 Spruce Street, Philadelphia, PA 19104. Back

5 Abbreviations used in this paper: Tg, transgenic; HA, hemagglutinin; S1, site 1; CFSE, 5-(and 6-)carboxyfluorescein diacetate succinimidyl ester; LN, lymph node; PR8, A/PR/8/34; TS1neg, TS1-negative. Back

Received for publication April 20, 2000. Accepted for publication August 1, 2000.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Kappler, J. W., N. Roehm, P. Marrack. 1987. T cell tolerance by clonal elimination in the thymus. Cell 49:273.[Medline]
  2. Kisielow, P., H. Bluthmann, U. D. Staerz, M. Steinmetz, H. von Boehmer. 1988. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 333:742.[Medline]
  3. Zal, T., A. Volkmann, B. Stockinger. 1994. Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a blood-borne self-antigen. J. Exp. Med. 180:2089.[Abstract/Free Full Text]
  4. Akkaraju, S., W. Y. Ho, D. Leong, K. Canaan, M. M. Davis, C. C. Goodnow. 1997. A range of CD4 T cell tolerance: partial inactivation to organ-specific antigen allows nondestructive thyroiditis or insulitis. Immunity 7:255.[Medline]
  5. Quill, H.. 1996. Anergy as a mechanism of peripheral T cell tolerance. J. Immunol. 156:1325.[Medline]
  6. Jordan, M. S., M. P. Riley, H. von Boehmer, A. J. Caton. 2000. Anergy and suppression regulate CD4+ T cell responses to a self peptide. Eur. J. Immunol. 30:136.[Medline]
  7. Kouskoff, V., A. S. Korganow, V. Duchatelle, C. Degott, C. Benoist, D. Mathis. 1996. Organ-specific disease provoked by systemic autoimmunity. Cell 87:811.[Medline]
  8. Ohashi, P. S., S. Oehen, K. Buerki, H. Pircher, C. T. Ohashi, B. Odermatt, B. Malissen, R. M. Zinkernagel, H. Hengartner. 1991. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 65:305.[Medline]
  9. Oldstone, M. B., M. Nerenberg, P. Southern, J. Price, H. Lewicki. 1991. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 65:319.[Medline]
  10. Poplonski, L., B. Vukusic, J. Pawling, S. Clapoff, J. Roder, N. Hozumi, J. Wither. 1996. Tolerance is overcome in beef insulin-transgenic mice by activation of low-affinity autoreactive T cells. Eur. J. Immunol. 26:601.[Medline]
  11. Cerasoli, D. M., J. McGrath, S. R. Carding, F. F. Shih, B. B. Knowles, A. J. Caton. 1995. Low avidity recognition of a class II-restricted neo-self peptide by virus-specific T cells. Int. Immunol. 7:935.[Abstract/Free Full Text]
  12. Heath, W. R., J. Allison, M. W. Hoffmann, G. Schonrich, G. Hammerling, B. Arnold, J. F. Miller. 1992. Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature 359:547.[Medline]
  13. Homer, R. J., C. Mamalaki, D. Kioussis, R. A. Flavell. 1993. T cell unresponsiveness correlates with quantitative TCR levels in a transgenic model. Int. Immunol. 5:1495.[Abstract/Free Full Text]
  14. Robey, E. A., F. Ramsdell, D. Kioussis, W. Sha, D. Loh, R. Axel, B. J. Fowlkes. 1992. The level of CD8 expression can determine the outcome of thymic selection. Cell 69:1089.[Medline]
  15. Teh, H. S., H. Kishi, B. Scott, H. Von Boehmer. 1989. Deletion of autospecific T cells in T cell receptor (TCR) transgenic mice spares cells with normal TCR levels and low levels of CD8 molecules. J. Exp. Med. 169:795.[Abstract/Free Full Text]
  16. Ashton-Rickardt, P. G., S. Tonegawa. 1994. A differential-avidity model for T-cell selection. Immunol. Today 15:362.[Medline]
  17. Heath, W. R., J. F. Miller. 1993. Expression of two {alpha} chains on the surface of T cells in T cell receptor transgenic mice. J. Exp. Med. 178:1807.[Abstract/Free Full Text]
  18. Sarukhan, A., C. Garcia, A. Lanoue, H. von Boehmer. 1998. Allelic inclusion of T cell receptor {alpha} genes poses an autoimmune hazard due to low-level expression of autospecific receptors. Immunity 8:563.[Medline]
  19. Zal, T., S. Weiss, A. Mellor, B. Stockinger. 1996. Expression of a second receptor rescues self-specific T cells from thymic deletion and allows activation of autoreactive effector function. Proc. Natl. Acad. Sci. USA 93:9102.[Abstract/Free Full Text]
  20. Heath, W. R., F. R. Carbone, P. Bertolino, J. Kelly, S. Cose, J. F. Miller. 1995. Expression of two T cell receptor {alpha}-chains on the surface of normal murine T cells. Eur. J. Immunol. 25:1617.[Medline]
  21. Padovan, E., G. Casorati, P. Dellabona, S. Meyer, M. Brockhaus, A. Lanzavecchia. 1993. Expression of two T cell receptor {alpha}-chains: dual receptor T cells. Science 262:422.[Abstract/Free Full Text]
  22. Liu, G. Y., P. J. Fairchild, R. M. Smith, J. R. Prowle, D. Kioussis, D. C. Wraith. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3:407.[Medline]
  23. Baldwin, K. K., B. P. Trenchak, J. D. Altman, M. M. Davis. 1999. Negative selection of T cells occurs throughout thymic development. J. Immunol. 163:689.[Abstract/Free Full Text]
  24. Spain, L. M., L. J. Berg. 1992. Developmental regulation of thymocyte susceptibility to deletion by "self"-peptide. J. Exp. Med. 176:213.[Abstract/Free Full Text]
  25. Vasquez, N. J., J. Kaye, S. M. Hedrick. 1992. In vivo and in vitro clonal deletion of double-positive thymocytes. J. Exp. Med. 175:1307.[Abstract/Free Full Text]
  26. Shih, F. F., D. M. Cerasoli, A. J. Caton. 1997. A major T cell determinant from the influenza virus hemagglutinin (HA) can be a cryptic self peptide in HA transgenic mice. Int. Immunol. 9:249.[Abstract/Free Full Text]
  27. Kirberg, J., A. Baron, S. Jakob, A. Rolink, K. Karjalainen, H. von Boehmer. 1994. Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor. J. Exp. Med. 180:25.[Abstract/Free Full Text]
  28. Karasuyama, H., F. Melchers. 1988. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18:97.[Medline]
  29. Wells, A. D., H. Gudmundsdottir, L. A. Turka. 1997. Following the fate of individual T cells throughout activation and clonal expansion. Signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100:3173.[Medline]
  30. Oehen, S., L. Feng, Y. Xia, C. D. Surh, S. M. Hedrick. 1996. Antigen compartmentation and T helper cell tolerance induction. J. Exp. Med. 183:2617.[Abstract/Free Full Text]
  31. Lanoue, A., C. Bona, H. von Boehmer, A. Sarukhan. 1997. Conditions that induce tolerance in mature CD4+ T cells. J. Exp. Med. 185:405.[Abstract/Free Full Text]
  32. Girgis, L., M. M. Davis, B. Fazekas de St. Groth.. 1999. The avidity spectrum of T cell receptor interactions accounts for T cell anergy in a double transgenic model. J. Exp. Med. 189:265.[Abstract/Free Full Text]
  33. Riley, M. P., F. F. Shih, M. S. Jordan, A. L. Petrone, D. M. Cerasoli, P. Scott, and A. J. Caton. 2000. CD4+ T cells that evade deletion by a self peptide display Th1-biased differentiation. Eur. J. Immunol. In press.



This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Larkin III, A. L. Rankin, C. C. Picca, M. P. Riley, S. A. Jenks, A. J. Sant, and A. J. Caton
CD4+CD25+ Regulatory T Cell Repertoire Formation Shaped by Differential Presentation of Peptides from a Self-Antigen
J. Immunol., February 15, 2008; 180(4): 2149 - 2157.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. L. Rankin, A. J. Reed, S. Oh, C. Cozzo Picca, H. M. Guay, J. Larkin III, L. Panarey, M. K. Aitken, B. Koeberlein, P. E. Lipsky, et al.
CD4+ T Cells Recognizing a Single Self-Peptide Expressed by APCs Induce Spontaneous Autoimmune Arthritis
J. Immunol., January 15, 2008; 180(2): 833 - 841.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. Boesteanu, A. L. Rankin, and A. J. Caton
Impact of effector cell differentiation on CD4+ T cells that evade negative selection by a self-peptide
Int. Immunol., July 1, 2006; 18(7): 1017 - 1027.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
F. F. Shih, J. Racz, and P. M. Allen
Differential MHC Class II Presentation of a Pathogenic Autoantigen during Health and Disease
J. Immunol., March 15, 2006; 176(6): 3438 - 3448.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Sinha, H. H. Chi, H. R. Kim, B. E. Clausen, B. Pederson, E. E. Sercarz, I. Forster, and K. D. Moudgil
Mouse Lysozyme-M Knockout Mice Reveal How the Self-Determinant Hierarchy Shapes the T Cell Repertoire against This Circulating Self Antigen in Wild-Type Mice
J. Immunol., August 1, 2004; 173(3): 1763 - 1771.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Lerman, J. Larkin III, C. Cozzo, M. S. Jordan, and A. J. Caton
CD4+ CD25+ Regulatory T Cell Repertoire Formation in Response to Varying Expression of a neo-Self-Antigen
J. Immunol., July 1, 2004; 173(1): 236 - 244.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
F. F. Shih, L. Mandik-Nayak, B. T. Wipke, and P. M. Allen
Massive Thymic Deletion Results in Systemic Autoimmunity through Elimination of CD4+ CD25+ T Regulatory Cells
J. Exp. Med., February 2, 2004; 199(3): 323 - 335.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Trani, D. J. Moore, B. P. Jarrett, J. W. Markmann, M. K. Lee, A. Singer, M.-M. Lian, B. Tran, A. J. Caton, and J. F. Markmann
CD25+ Immunoregulatory CD4 T Cells Mediate Acquired Central Transplantation Tolerance
J. Immunol., January 1, 2003; 170(1): 279 - 286.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. J. Reed, M. P. Riley, and A. J. Caton
Virus-Induced Maturation and Activation of Autoreactive Memory B Cells
J. Exp. Med., December 18, 2000; 192(12): 1763 - 1774.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riley, M. P.
Right arrow Articles by Caton, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riley, M. P.
Right arrow Articles by Caton, A. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS